HEDRICK MARC H 4/A
4/A · PLUS THERAPEUTICS, INC. · Filed Oct 3, 2025
Insider Transaction Report
Form 4/AAmended
HEDRICK MARC H
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-08-13+5,748,506→ 5,748,506 totalExercise: $0.57Exp: 2035-08-12→ Common Stock (5,748,506 underlying) - Award
Restricted Stock Units
2025-08-13+1,916,168→ 1,916,168 total→ Common Stock (1,916,168 underlying)
Footnotes (2)
- [F1]The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.
- [F2]This amendment is being filed to correct a Form 4 filed on August 15, 2025, which inadvertently disclosed the incorrect vesting terms of the Restricted Stock Units ("RSUs"). The RSUs awarded on August 13, 2025 vest over twelve quarters, vesting in substantially equal 1/12th increments beginning with the quarter ended September 30, 2025. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.